Nathan Frank
Optometrist · Anchorage, AKNPI 1588812390
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 57.7% of the total. Reporting peaked in 2022 at $2,274 and has fallen 94.0% since, to $137 in 2024. Among optometrist clinicians in AK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $66.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$2K
- Alcon$304
- Sun Pharmaceutical Industries Inc.$249
- AbbVie$195
- Novartis$146
- Sight Sciences, Inc.$103
- plus $488 from 9 others
What the payments were for
- Consulting fees$2,02558%
- Food & beverage$1,46642%
- Education$181%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 1 | $2,025 |
| Alcon | 9 | $304 |
| Sun Pharmaceutical Industries Inc. | 4 | $249 |
| AbbVie(2 entities) | 9 | $195 |
| Novartis | 7 | $146 |
| Sight Sciences, Inc. | 3 | $103 |
| Bausch & Lomb Americas Inc. | 5 | $95 |
| Dompe US, Inc. | 4 | $91 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $75 |
| Oyster Point Pharma, Inc. | 3 | $66 |
| Mallinckrodt Hospital Products Inc. | 3 | $61 |
| Maculogix, Inc. | 1 | $36 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $32 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,509 in reported general payments places this provider in the 90th percentile of 163 optometrist providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 15 | $24,713 |
| TyrvayaVarenicline Tartrate | 12 | $7,616 |
| Loteprednol Etabonate | 20 | $3,947 |
| Latanoprost | 13 | $382 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra | $95 | $24,71315 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $66 | $7,61612 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $75 | $3,94720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 163 optometrist providers in Alaska.
Other optometrist in Anchorage
- Andrea EberleAnchorage$10K
- Steven DobsonAnchorage$6K
- Herbert WentzienAnchorage$5K
- Nhan TranAnchorage$5K
- Bethany BeckerAnchorage$5K
- Elizabeth BowAnchorage$4K
- Anthony MakarAnchorage$4K
- Gary KjomeAnchorage$4K
- Christie StemmleAnchorage$4K
- Rebecca MakarAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.